Nematic liquid crystal composition

Information

  • Patent Grant
  • 9605208
  • Patent Number
    9,605,208
  • Date Filed
    Wednesday, July 24, 2013
    11 years ago
  • Date Issued
    Tuesday, March 28, 2017
    7 years ago
Abstract
A liquid crystal composition exhibits a positive dielectric anisotropy and sufficiently low viscosity without decreasing or increasing refractive index anisotropy or nematic phase-isotropic liquid phase transition temperature, and does not cause display failures. The liquid crystal composition contains one or more compounds selected from compounds represented by general formula (LC0) and one or more compounds selected from a group of compounds represented by general formula (LC1) to general formula (LC5), in which the liquid crystal composition contains one or more compounds in which at least one of A01, A02, and A11 to A42 in general formulae (LC0) to (LC4) represents a tetrahydropyran-2,5-diyl group.
Description
TECHNICAL FIELD

The present invention relates to a nematic liquid crystal composition useful as an electro-optic liquid crystal display material and having positive dielectric anisotropy (Δ∈).


BACKGROUND ART

Liquid crystal display devices are being used in watches, calculators, various measurement instruments, automobile panels, word processors, electronic organizers, printers, computers, televisions, clocks, advertising boards, etc. Typical examples of the liquid crystal display mode include TN (twisted nematic) mode, STN (super twisted nematic) mode, a VA mode featuring vertical alignment using TFTs (thin film transistors), and an IPS (in-plane switching) mode/FFS mode featuring horizontal alignment. Liquid crystal compositions used in these liquid crystal display devices are required to be stable against external factors such as moisture, air, heat, and light, stay in a liquid crystal phase in a temperature range as wide as possible centered around room temperature, exhibit low viscosity, and operate at a low drive voltage. A liquid crystal composition is composed of several to dozens of compounds in order to optimize the dielectric anisotropy (Δ∈), refractive index anisotropy (Δn), and/or other properties for individual display devices.


A vertical alignment-mode display uses a liquid crystal composition having a negative Δ∈. A horizontal alignment-mode display such as a TN, STN, or IPS-mode display uses a liquid crystal composition having a positive Δ∈. In recent years, a drive mode with which a liquid crystal composition having a positive Δ∈ is vertically aligned under absence of applied voltage and an image is displayed by applying an IPS/FFS-mode electric field has been reported and the necessity for a liquid crystal composition having a positive Δ∈ is increasing. Meanwhile, low-voltage driving, high-speed response, and wide operation temperature range are required in all driving modes. In other words, Δ∈ that is positive and has a large absolute value, a low viscosity (η), and a high nematic phase-isotropic liquid phase transition temperature (Tni) are desirable. Moreover, due to the setting of Δn×d, which is the product of Δn and a cell gap (d), it is necessary to adjust the Δn of the liquid crystal composition to be within an appropriate range according to the cell gap. In addition, since high-speed response is important in applying a liquid crystal display device to a television or the like, a liquid crystal composition with a small γ1 is required.


Liquid crystal compositions that use a compound having a positive Δ∈ and represented by formula (A-1) or (A-2) as a constitutional component of a liquid crystal composition have been disclosed (PTL 1 to PTL 4). However, these liquid crystal compositions do not achieve sufficiently low viscosity.




embedded image


CITATION LIST
Patent Literature

PTL 1: WO96/032365


PTL 2: Japanese Unexamined Patent Application Publication No. 09-157202


PTL 3: WO98/023564


PTL 4: Japanese Unexamined Patent Application Publication No. 2003-183656


SUMMARY OF INVENTION
Technical Problem

An object of the present invention is to provide a liquid crystal composition that has refractive index anisotropy (Δn) adjusted to a desired level and a positive dielectric anisotropy (Δ∈) and exhibits sufficiently low viscosity (η) without degrading the nematic phase temperature range by suppressing the decrease in the nematic phase-isotropic liquid phase transition temperature (Tni) and the increase in lower limit temperature of the nematic phase.


Solution to Problem

The inventors of the present invention have studied various fluorobenzene derivatives and found that the object can be achieved by combining specific compounds. Thus, the present invention has been made.


The present invention provides a liquid crystal composition having a positive dielectric anisotropy and containing one or more compounds selected from compounds represented by general formula (LC0) and one or more compounds selected from a group of compounds represented by general formula (LC1) to general formula (LC5), wherein the liquid crystal composition contains one or more compounds in which at least one of A01, A02, and A11 to A42 in general formulae (LC0) to (LC4) represents a tetrahydropyran-2,5-diyl group:




embedded image



(In the formulae, R01 to R41 each independently represent an alkyl group having 1 to 15 carbon atoms where one or more —CH2— in the alkyl group may each be substituted with —O—, —CH═CH—, —CO—, —OCO—, —COO—, —C≡C—, —CF2O—, or —OCF2— so long as oxygen atoms are not directly adjacent to each other and one or more hydrogen atoms in the alkyl group may each be substituted with a halogen; R51 and R52 each independently represent an alkyl group having 1 to 15 carbon atoms where one or more —CH2— in the alkyl group may each be substituted with —O—, —CH═CH—, —CO—, —OCO—, —COO—, or —C≡C— so long as oxygen atoms are not directly adjacent to each other, and may each represent —OCF3 or —CF3— when A51 or A53 described below represents a cyclohexane ring; A01 to A42 each independently represent any one of structures below:




embedded image



(In the structures, one or more —CH2— in the cyclohexane ring may each be substituted with —O— so long as oxygen atoms are not directly adjacent to each other; in the structures, one or more —CH═ in the benzene ring may each be substituted with —N═ so long as nitrogen atoms are not directly adjacent to each other; and X61 and X62 each independently represent —H, —Cl, —F, —CF3, or —OCF3); A51 to A53 each independently represent any one of structures below:




embedded image



(In the formulae, one or more —CH2CH2— in the cyclohexane ring may each be substituted with —CH═CH—, —CF2O—, or —OCF2— and one or more —CH═ in the benzene ring may each be substituted with —N═ so long as nitrogen atoms are not directly adjacent to each other); X01 represents a hydrogen atom or a fluorine atom; X11 to X43 each independently represent —H, —Cl, —F, —CF3, or —OCF3; Y each Y01 to Y41 represent —Cl, —F, —OCHF2, —CF3, or —OCF2; Z01 and Z02 each independently represent a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —OCF2—, or —CF2O—; Z31 to Z42 each independently represent a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —OCF2—, or —CF2O— where at least one of Z31 and Z32 that are present represents a group other than a single bond; Z51 and Z52 each independently represent a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —OCH2—, —CH2O—, —OCF2— or —CF2O—; m01 to m51 each independently represent an integer of 0 to 3; m01+m02, m31+m32, and m41+m42 are each independently 1, 2, 3, or 4; and when a plurality of A01, A03, A23, A31, A32, A41, A42, A52, Z01, Z02, Z31, Z32, Z41, Z42, and/or Z52 are present, they may be the same or different).


Advantageous Effects of Invention

The liquid crystal composition according to the present invention features a positive Δ∈ having a large absolute value. Moreover, η is low, the rotational viscosity (γ1) is small, the liquid crystal properties are excellent, and a stable liquid crystal phase is achieved over a wide temperature range. Moreover, the liquid crystal composition is chemically stable against heat, light, water, etc., can be driven at a low voltage, is practical, and has high reliability.







DESCRIPTION OF EMBODIMENTS

A liquid crystal composition according to the invention of the present application contains one or more compounds selected from compounds represented by general formula (LC0) above and one or more compounds selected from a compound group consisting of compounds represented by general formulae (LC1) to (LC5). Since a liquid crystal composition containing compounds represented by general formula (LC0) and compounds represented by general formulae (LC1) to (LC5) exhibits a stable liquid crystal phase even at low temperature, the liquid crystal composition can be regarded as a practical liquid crystal composition.


In general formulae (LC0) to (LC5), R01 to R52 preferably each independently represent an alkyl group having 1 to 8 carbon atoms, an alkenyl group having 2 to 8 carbon atoms, or an alkoxy group having 1 to 8 carbon atoms and are preferably linear. When R01 to R52 are to represent alkenyl groups, selection is preferably made from groups represented by formulae (R1) to (R5):




embedded image



(In each formula, the black dot represents a bonding point to a ring.)


In the case where A01, A01, A21, A31, A41, A51, and A53 each represent a trans-1,4-cyclohexylene group, groups represented by formulae (R1), (R2), and (R4) are more preferable. It is yet more preferable to contain one or more compounds represented by general formula (LC5) in which at least one selected from R51 and R53 represents an alkenyl group represented by a formula selected from formulae (R1) to (R5). A01 to A42 preferably each independently represent a trans-1,4-cyclohexylene group, a 1,4-phenylene group, a 3-fluoro-1,4-phenylene group, a 3,5-difluoro-1,4-phenylene group, or a tetrahydropyran-2,5-diyl group. In the case where some of A01 to A42 are to represent a tetrahydropyran-2,5-diyl group, A01, A11, A21, A31, and A41 preferably represent this group. Examples of preferable compounds containing a tetrahydropyran-2,5-diyl group include compounds represented by general formula (LC0-7) to general formula (LC0-9), general formula (LC0-23), general formula (LC0-24), general formula (LC0-26), general formula (LC0-27), general formula (LC0-20), general formula (LC0-40), general formula (LC0-51) to general formula (LC0-53), general formula (LC0-110), general formula (LC0-111), general formula (LC2-9) to general formula (LC2-14), general formula (LC3-23) to general formula (LC3-32), general formula (LC4-12) to general formula (LC4-14), general formula (LC4-16), general formula (LC4-19), and general formula (LC4-22). In such a case, at least one compound selected from this compound group is more preferably contained in order to achieve the object of the present invention.


A51 to A53 preferably each independently represent a trans-1,4-cyclohexylene group, a 1,4-phenylene group, a 3-fluoro-1,4-phenylene group, or a 2-fluoro-1,4-phenylene group.


Z01 and Z02 preferably each independently represent a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —OCF2—, or —CF2O—. In the case where one of Z01 and Z02 that are present represents —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —OCF2—, or —CF2O—, the other preferably represents a single bond. Z01 and Z02 preferably both represent a single bond.


Z31 to Z42 preferably each independently represent a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —OCH2—, —CH2O—, —OCF2—, or —CF2O—. In the case where one of Z31 to Z42 that are present represents —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —OCF2—, or —CF2O—, the others preferably each represent a single bond.


Z51 and Z52 preferably each independently represent a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —OCF2—, or —CF2O—. In the case where one of Z51 and Z52 that are present represents —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —OCH2—, —CH2O—, —OCF2—, or —CF2O—, the other preferably represents a single bond. More preferably, Z51 and Z52 both represent a single bond.


X01 in general formula (LC0) is preferably F since a significantly low viscosity (η) is achieved relative to a high dielectric anisotropy (Δ∈) or the same level of dielectric anisotropy (Δ∈). X11 to X43 preferably each independently represent H or F, and X11, X21, X31, and X41 preferably each represent F.


Y01 to Y41 particularly preferably each independently represent F, CF3, or OCF3. While m01 to m51 may each independently represent an integer of 0 to 23, m01+m02 is particularly preferably 1 or 2, m21 is particularly preferably 0, m31+m32 is particularly preferably 1, 2, or 3, and m41+m42 is particularly preferably 1 or 2.


The liquid crystal compound represented by general formula (LC0) is preferably a compound represented by any one of general formula (LC0-a) to (LC0-h) (in the formulae, R01, A01, A02, A03, Z01, Z02, X01, and Y01 are the same as those in general formula (LC0) and when two or more A01 and A03, and/or Z01 and Z02 are present, they may be the same or different).




embedded image


More preferable are the compounds represented by general formula (LC0-1) to general formula (LC0-111) below:




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image



(In the formulae, R is the same as R01 in general formula (LC0), “—F, CF3, OCF3” denotes that Y01 each independently represent one of —F, CF3, and OCF3, and “(—F)” denotes H or F serving as a substituent.) Compounds represented by general formula (LC0-1) to general formula (LC0-19) are particularly preferable since they have high dielectric anisotropy (Δ∈), notably low viscosity (η), and good compatibility. Compounds represented by general formulae (LC0-20) to general formula (LC0-111) are particularly preferable since they have high dielectric anisotropy (Δ∈), relatively low viscosity (11), and a high nematic phase-isotropic liquid phase transition temperature (Tni).


The compounds represented by general formula (LC2) are more preferably compounds represented by general formula (LC2-1) to general formula (LC2-14) below:




embedded image


embedded image



(In the formulae, X23, X24, X25, and X26 each independently represent a hydrogen atom, Cl, F, CF3, or OCF3, and X22, R21, and Y21 are the same as those in general formula (LC2)). The group of compounds represented by general formula (LC2-1) to general formula (LC2-4) and general formula (LC2-9) to general formula (LC2-11) is more preferable.


The compounds represented by general formula (LC3) are more preferably compounds represented by general formula (LC3-1) to general formula (LC3-32) below:




embedded image


embedded image


embedded image


embedded image


embedded image



(In the formulae, X33, X34, X35, X36, X37, and X38 each independently represent H, Cl, F, CF3, or OCF3, and X32, R31, A31, Y31, and Z31 are the same as those in general formula (LC3).) Among these, the group of the compounds represented by general formula (LC3-5), general formula (LC3-15), and general formula (LC3-20) to general formula (LC3-32) is more preferably used in combination with the essential component of the present invention represented by general formula (LC0). More preferably, a compound selected from the group of compounds represented by general formula (LC3-20) and general formula (LC3-21) with X33 and X34 each representing F and/or the group of tetrahydropyran-ring-containing compounds represented by general formula (LC3-25), general formula (LC3-26), and general formula (LC3-30) to general formula (LC3-32) are preferably used in combination with the essential component of the present invention represented by general formula (LC0).


The compounds represented by general formula (LC4) are more preferably compounds represented by general formula (LC4-1) to general formula (LC4-23) below:




embedded image


embedded image


embedded image


embedded image



(In the formulae, X44, X45, X46, and X47 each independently represent H, Cl, F, CF3, or OCF3, and X42, X43, R41, and Y41 are the same as those in general formula (LC4).) Among these, the group of compounds represented by general formula (LC4-1) to general formula (LC4-3), general formula (LC4-6), general formula (LC4-9), general formula (LC4-10), and general formula (LC4-12) to general formula (LC4-17) are more preferably used in combination with the essential component of the present invention represented by general formula (LC0). Furthermore, among these, a compound selected from the group of compounds represented by general formula (LC4-9) to general formula (LC4-11) and general formula (LC4-15) to general formula (LC4-17) with X44 and/or X45 representing F is more preferably used in combination with the essential component of the present invention represented by general formula (LC0).


The compounds represented by general formula (LC5) are more preferably compounds represented by general formula (LC5-1) to general formula (LC5-26) below:




embedded image


embedded image


embedded image



(In the formulae, R51 and R52 are the same as those in general formula (LC5).) Among these, the group of compounds represented by general formula (LC5-1) to general formula (LC5-8), general formula (LC5-14), general formula (LC5-16), and general formula (LC5-18) to general formula (LC5-26) is particularly preferably used in combination with the essential component of the present invention represented by general formula (LC0). At least one of R51 and R52 in general formula (LC5-1) and general formula (LC5-4) preferably represents an alkenyl group and more preferably an alkenyl group selected from those represented by formulae (R1) to (R5) below.




embedded image


One or more compounds represented by general formula (LC5) are preferably contained. The content thereof is preferably 20 to 70% by mass and more preferably 30 to 70% by mass.


The liquid crystal composition of the present invention contains a compound represented by general formula (LC0) and a compound selected from the group of compounds represented by general formula (LC1) to general formula (LC5). Of these compounds, at least one compound is a compound having a tetrahydropyran-2,5-diyl group and the content thereof is preferably in the range of 5 to 50% by mass and more preferably in the range of 10 to 40% by mass. The compound having a tetrahydropyran-2,5-diyl group which is an essential component of the liquid crystal composition of the present invention is preferably a compound represented by general formula (LC0), at least one of A01 and A02 in general formula (LC0) preferably represents a tetrahydropyran-2,5-diyl group, and the content thereof is preferably 5 to 50% by mass.


The liquid crystal composition of the present invention preferably has a viscosity η of 20 mPa·s or less at 20° C.


The liquid crystal composition of the present invention may contain one or more optically active compounds. The optically active compounds may be any capable of twisting and aligning liquid crystal molecules. Since twisting normally changes depending on temperature, plural optically active compounds may be used to obtain a desired temperature dependence. In order not to adversely affect the nematic liquid crystal phase temperature range, viscosity, and the like, it is preferable to select and use optically active compounds that have a powerful twisting effect. Examples of such optically active compounds to be contained include liquid crystals such as cholesteric nonanoate and compounds represented by general formula (Ch-1) to general formula (Ch-6) below:




embedded image



(In the formulae, Rc1, Rc2, and R* each independently represent an alkyl group having 1 to 15 carbon atoms where one or more —CH2— in the alkyl group may each be substituted with —O—, —CH═CH—, —CO—, —OCO—, —COO—, —C≡C—, —CF2O—, or —OCF2— so long as oxygen atoms are not directly adjacent to each other and one or more hydrogen atoms in the alkyl group may each be substituted with a halogen; R* includes at least one optically active branched chain group or halogen substituent; Zc1 and Zc2 each independently represent a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —COO—, —OCO—, —OCH2—, —CH2O—, —OCF2—, or —CF2O—; D1 and D2 each represent a cyclohexane ring or a benzene ring where one or more —CH2— in the cyclohexane ring may each be substituted with —O— so long as oxygen atoms are not directly adjacent to each other, one or more —CH2CH2— in the ring may each be substituted with —CH═CH—, —CF2O—, or —OCF2—, one or more —CH═ in the benzene ring may each be substituted with —N═ so long as nitrogen atoms are not directly adjacent to each other, and one or more hydrogen atoms in the ring may each be substituted with F, Cl, or CH3; t1 and t2 each represent 0, 1, 2, or 3; and MG*, Qc1, and Qc2 each represent the structure below:




embedded image



(In the formula, D3 and D4 each represent a cyclohexane ring or a benzene ring, one or more —CH2— in the cyclohexane ring may each be substituted with —O— so long as oxygen atoms are not directly adjacent to each other, one or more —CH2CH2— in the ring may each be substituted with —CH═CH—, —CF2O—, or —OCF2—, one or more —CH═ in the benzene ring may each be substituted with —N═ so long as nitrogen atoms are not directly adjacent to each other, and one or more hydrogen atoms in the ring may each be substituted with F, Cl, or CH3.)


The liquid crystal composition of the present invention may contain one or more polymerizable compounds. The polymerizable compounds are preferably discotic liquid crystal compounds which have a benzene derivative, a triphenylene derivative, a truxene derivative, a phthalocyanine derivative, or a cyclohexane derivative as a core at the molecular center and linear alkyl groups, linear alkoxy groups, or substituted benzoyloxy groups as side chains radially substituting the core.


To be specific, the polymerizable compounds are preferably compounds represented by general formula (PC):




embedded image



(In the formula, P1 represents a polymerizable functional group, Sp1 represents a spacer group having 0 to 20 carbon atoms, Qp1 represents a single bond, —O—, —NH—, —NHCOO—, —OCONH—, —CH═CH—, —CO—, —COO—, —OCO—, —OCOO—, —OOCO—, —CH═CH—, —CH═CH—COO—, —OCO—CH═CH—, or —C≡C—, p1 and p2 each independently represent 1, 2, or 3, MGp represents a mesogenic group or a mesogenic supporting group, and Rp1 represents a halogen atom, a cyano group, or an alkyl group having 1 to 25 carbon atoms where one or more CH2 group in the alkyl group may each be substituted with —O—, —S—, —NH—, —N(CH3)—, —CO—, —COO—, —OCO—, —OCOO—, —SCO—, —COS—, or —C≡C— so long as oxygen atoms are not directly adjacent to each other, or Rp1 may represent P2-Sp2-Qp2- where P2, Sp2, and Qp2 are respectively the same as P1, Sp1, and Qp1.)


More preferably, the polymerizable compounds are those represented by general formula (PC) with MGp representing the following structure:




embedded image



(In the formula, C01 to C03 each independently represent a 1,4-phenylene group, a 1,4-cyclohexylene group, a 1,4-cyclohexenyl group, a tetrahydropyran-2,5-diyl group, a 1,3-dioxane-2,5-diyl group, a tetrahydrothiopyran-2,5-diyl group, a 1,4-bicyclo(2,2,2)octylene group, a decahydronaphthalene-2,6-diyl group, a pyridine-2,5-diyl group, a pyrimidine-2,5-diyl group, a pyradine-2,5-diyl group, a 1,2,3,4-tetrahydronaphthalene-2,6-diyl group, a 2,6-naphthylene group, a phenanthrene-2,7-diyl group, a 9,10-dihydrophenanthrene-2,7-diyl group, a 1,2,3,4,4a,9,10a-octahydrophenanthrene-2,7-diyl group, or a fluorene-2,7-diyl group; the 1,4-phenylene group, the 1,2,3,4-tetrahydronaphthalene-2,6-diyl group, the 2,6-naphthylene group, the phenanthrene-2,7-diyl group, the 9,10-dihydrophenanthrene-2,7-diyl group, the 1,2,3,4,4a,9,10a-octahydrophenanthrene-2,7-diyl group, and the fluorene-2,7-diyl group may each have, as a substituent, one or more selected from F, Cl, CF3, OCF3, a cyano group, an alkyl group having 1 to 8 carbon atoms, an alkoxy group, an alkanoyl group, an alkanoyloxy group, an alkenyl group having 2 to 8 carbon atoms, an alkenyloxy group, an alkenoyl group, and an alkenoyloxy group; Zp1 and Zp2 each independently represent —COO—, —OCO—, —CH2CH2—, —OCH2—, —CH2O—, —CH═CH—, —C≡C—, —CH═CHCOO—, —OCOCH═CH—, —CH2CH2COO—, —CH2CH2OCO—, —COOCH2CH2—, —OCOCH2CH2—, —CONH—, —NHCO—, or a single bond; and p3 represents 0, 1, or 2.)


In the case where Sp1 and Sp2 each independently represent an alkylene group, the alkylene group may be substituted with one or more halogen atoms or CN and one or more CH2 groups present in this group may each be substituted with —O—, —S—, —NH—, —N(CH2)—, —CO—, —COO—, —OCO—, —OCOO—, —SCO—, —COS—, or —C≡C— so long as oxygen atoms are not directly adjacent to each other. P1 and P2 preferably each independently represent a group selected from those represented by general formulae below:




embedded image



(In the formulae, Rp2 to Rp6 each independently represent a hydrogen atom, a halogen atom, or an alkyl group having 1 to 5 carbon atoms.)


To be more specific, the polymerizable compounds represented by general formula (PC) are preferably compounds represented by general formula (PC0-1) to general formula (PC0-6) below:

[Chem. 23]
(P1-Sp1-Qp1private use character Parenclosestp1MGpprivate use character ParenopenstQp2-Sp2-P2)p4  (PC0-1)
(P1-Qp1private use character Parenclosestp1MGpprivate use character ParenopenstQp2-P2)p4  (PC0-2)
P1-Sp1-Qp1-MGp-Qp2-Sp2-P2  (PC0-3)
P1-Qp1-MGp-Qp2-P2  (PC0-4)
P1-Sp1-Qp1-MGp-Rp1  (PC0-5)
P1-Qp1-MGp-Rp1  (PC0-6)

(In the formulae, p4 each independently represent 1, 2, or 3.) The polymerizable compounds represented by general formula (PC0) are more preferably compounds represented by more specific formulae, namely, general formula (PC1-1) to general formula (PC1-9) below:




embedded image



(In the formulae, p5 represents 0, 1, 2, 3, or 4.)


More preferable are polymerizable compounds represented by general formula (PC) to general formula (PC1-9) with Sp1, Sp2, Qp1, and Qp2 all representing single bonds, polymerizable compounds with P1 and P2 representing a group represented by formula (PC0-a), an acrylate, and/or a methacrylate, polymerizable compounds represented by general formula (PC0-1) and general formula (PC0-2) with p1 and p4 satisfying p1+p4=1 to 6, and polymerizable compounds represented by general formula (PC1-1) and general formula (PC1-9) with Rp1 representing F, CF3, OCF3, CH3, or OCH3, where the number of substituents Rp1 is 1, 2, 3, or 4.


Also preferable is a discotic liquid crystal compound represented by general formula (PC) with MGp representing a group represented by general formula (PC1)-9.




embedded image



(In the formulae, R7 each independently represent P1-Sp1-Qp1 or a substituent represented by general formula (PC1-e), R81 and R82 each independently represent a hydrogen atom, a halogen atom, or a methyl group, R83 represents an alkoxy group having 1 to 20 carbon atoms, and at least one of hydrogen atoms in the alkoxy group is substituted with a substituent represented by any one of general formulae (PC0-a) to (PC0-d) above.) The amount of the polymerizable compounds used is preferably 0.05 to 2.0% by mass.


The liquid crystal composition of the present invention containing a polymerizable compound is used to manufacture a liquid crystal composition through polymerizing the polymerizable compound. During this process, the amount of the unpolymerized components is preferably decreased to a desired level or less. A liquid crystal composition of the present invention suited for this use preferably contains a compound having a biphenyl group or a terphenyl group as a partial structure in general formula (LC0). More specifically, it is preferable to use 0.1 to 40% by mass of at least one selected from the group of compounds represented by general formula (LC0-4) to general formula (LC0-6), general formula (LC0-10) to general formula (LC0-16), and general formula (LC0-27) to general formula (LC0-107). The compound is preferably used in combination with a polymerizable compound selected from those represented by general formula (PL1-1) to general formula (PL1-3), general formula (PC1-8), and general formula (PC1-9).


The liquid crystal composition may further contain one or more antioxidants and one or more UV absorbers. The antioxidant is preferably selected from those represented by general formula (E-1) and/or general formula (E-2) below:




embedded image



(In the formulae, Re1 represents an alkyl group having 1 to 15 carbon atoms, one or more —CH2— in the alkyl group may each be substituted with —O—, —CH═CH—, —CO—, —OCO—, —COO—, —C≡C—, —CF2O—, or —OCF2— so long as oxygen atoms are not directly adjacent to each other, and one or more hydrogen atoms in the alkyl group may each be substituted with a halogen;


Ze1 and Ze2 each independently represent a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —COO—, —OCO—, —OCH2—, —CH2O—, —OCF2—, or —CF2O—; and


E1 represents a cyclohexane ring or a benzene ring, one or more —CH2— in the cyclohexane ring may each be substituted with —O— so long as oxygen atoms are not directly adjacent to each other, one or more —CH2CH2— in the ring may each be substituted with —CH═CH—, —CF2O—, or —OCF2—, one or more —CH═ in the benzene ring may each be substituted with —N═ so long as nitrogen atoms are not directly adjacent to each other, one or more hydrogen atoms in the ring may each be substituted with F, Cl, or CH3, and q1 represents 0, 1, 2, or 3.)


The liquid crystal composition according to the present invention can be used in liquid crystal display devices, in particular, active matrix driving liquid crystal display devices of, for example, TN mode, OCB mode, ECB mode, IPS (including FFS electrodes) mode, or VA-IPS mode (including FFS electrodes). Here, the VA-IPS mode refers to a driving mode in which a liquid crystal material having a positive dielectric anisotropy (Δ∈>0) is vertically aligned with respect to the substrate surface in the absence of applied voltage and liquid crystal molecules are driven by using pixel electrodes and a common electrode arranged on the same substrate surface. Since liquid crystal molecules align in a direction of the curved electric field generated by the pixel electrodes and the common electrode, it is easy to divide pixels into sub-areas to form a multi-domain structure and enhance response. Such a system is referred to as EOC, VA-IPS, etc., according to Non-Patent Literatures Proc. 13th IDW, 97 (1997), Proc. 13th IDW, 175 (1997), SID Sym. Digest, 319 (1998), SID Sym. Digest, 838 (1998), SID Sym. Digest, 1085 (1998), SID Sym. Digest, 334 (2000), and Eurodisplay Proc., 142 (2009). In the present invention, the name “VA-IPS” is used.


In general, the threshold voltage (Vc) of the Freedericksz transition for TN and ECB mode is determined by the following expression:









Vc
=



π






d
cell




d
cell

+



r
1









K





11

Δɛ







[

Math
.




1

]







Vc for STN mode is determined by the following expression:









Vc
=



π






d
gap




d
cell

+



r
2









K





22

Δɛ







[

Math
.




2

]







Vc for VA mode is determined by the following expression:









Vc
=



π






d
cell




d
cell

-



r
3









K





33



Δɛ









[

Math
.




3

]








(In the expressions, Vc denotes the Freedericksz transition (V), π denotes the circular constant, dcell denotes the gap (μm) between a first substrate and a second substrate, dgap denotes the gap (μm) between the pixel electrodes and the common electrode, dITO denotes the width (μm) of the pixel electrodes and/or the common electrode, <r1>, <r2>, and <r3> denote the extrapolation length (μm), K11 denotes the splay elastic constant (N), K22 denotes the twist elastic constant (N), K33 denotes the bend elastic constant (N), and Δ∈ denotes the dielectric anisotropy.)


It has been found that the following mathematical expression 4 is applicable to the present invention etc., for VA-IPS mode:









Vc





d
gap

-



r







d
ITO

+


r







π






d
cell




d
cell

-



r
3









K





33



Δɛ









[

Math
.




4

]








(In the expression, Vc denotes the Freedericksz transition (V), n denotes the circular constant, dcell denotes the gap (μm) between a first substrate and a second substrate, dgap denotes the gap (μm) between the pixel electrodes and the common electrode, dITO denotes the width (μm) of the pixel electrodes and/or the common electrode, <r>, <r′>, and <r3> denote the extrapolation length (μm), K33 denotes the bend elastic constant (N), and Δ∈ denotes the dielectric anisotropy.) Mathematical expression 4 shows that the cell structure may be designed to decrease dgap as much as possible and increase dITO as much as possible to achieve low drive voltage and that a liquid crystal composition having Δ∈ with a large absolute value and a low K33 may be selected as the liquid crystal composition to achieve low drive voltage.


The liquid crystal composition of the present invention can be adjusted to exhibit desirable Δ∈, K11, K33, etc.


The product (Δn·d) of the refractive index anisotropy (Δn) of the liquid crystal composition and the gap (d) between the first substrate and the second substrate of a display device is strongly related to viewing angle characteristics and response speed. Accordingly, the gap (d) tends to be as small as 3 to 4 μm. The product (Δn·d) is particularly preferably 0.31 to 0.33 for the TN, ECB, and IPS (liquid crystal aligns substantially horizontal to the substrate surface in the absence of applied voltage) modes. For the VA-IPS mode, the product is preferably 0.20 to 0.59 and more preferably 0.30 to 0.40 if the alignment is vertical with respect to the two substrates. Since the suitable value of the product (Δn·d) differs depending on the mode of the display device, a liquid crystal composition capable of exhibiting a refractive index anisotropy (Δn) in various different ranges, such as 0.070 to 0.110, 0.100 to 0.140, or 0.130 to 0.180 is required. In order to obtain a small or relatively small refractive index anisotropy (Δn) from the liquid crystal composition of the present invention, it is preferable to use 0.1 to 80% by mass of one or more compounds selected from the group consisting of compounds represented by general formula (LC0-1) to general formula (LC0-3), general formula (LC0-7) to general formula (LC0-9), and general formula (LC0-20) to general formula (LC0-30). In order to obtain a large or relatively large refractive index anisotropy (Δn), it is preferable to use 0.1 to 60% by mass of one or more compounds selected from the group consisting of compounds represented by general formula (LC0-4) to general formula (LC0-6), general formula (LC0-10) to general formula (LC0-16), and general formula (LC0-27) to general formula (LC0-107). For the TN and ECB modes that require the liquid crystal to align substantially horizontal to the substrate surface in the absence of applied voltage, the tilt angle is preferably 0.5 to 7°. For the VA-IP mode that requires the liquid crystal to align substantially perpendicular to the substrate surface in the absence of applied voltage, the tilt angle is preferably 85 to 90°. In order to have the liquid crystal composition aligned in such a manner, alignment films composed of polyimide (PI), polyamide, chalcone, cinnamate, cinnamoyl, or the like may be provided. The alignment films are preferably formed by using an optical alignment technology. A liquid crystal composition of the present invention containing a compound represented by general formula (LC0) having a partial structure in which X01 represents F can be easily aligned along the easy axis of the alignment films and the desired tilt angle can be easily formed.


A liquid crystal composition of the present invention containing a compound represented by general formula (PC) as the polymerizable compound can be used to form a polymer-stabilized TN-mode, OCB-mode, ECB-mode, IPS-mode, or VA-IPS mode liquid crystal display device prepared by polymerizing the polymerizable compounds in the liquid crystal composition in the presence or absence of applied voltage.


EXAMPLES

The present invention will now be described in further detail by using Examples which do not limit the scope of the present invention. Note that the “%” for compositions of Examples and Comparative Examples below means “% by mass”.


The physical properties of the liquid crystal composition are presented as follows:


TN-I: nematic phase-isotropic liquid phase transition temperature (° C.)


T-n: lower limit temperature (° C.) of nematic phase


∈⊥: dielectric constant in a direction perpendicular to the molecular long axis at 25° C.


Δ∈: dielectric anisotropy at 25° C.


no: refractive index for ordinary rays at 25° C.


Δn: refractive index anisotropy at 25° C.


Vth: voltage (V) applied to a 6 μm-thick cell at which the transmittance changes by 10% when square waves are applied at a frequency of 1 KHz at 25° C.


Viscosity: bulk viscosity (mPa·s) at 20° C.


γ1: rotational viscosity (mPa·s)


Compounds are abbreviated as follows:










TABLE 1





n (numeral) at terminus
CnH2n+1







-2-
—CH2CH2


-1O-
—CH2O—


-O1-
—OCH2


—V—
—CO—


—VO—
—COO—


—CFFO—
—CF2O—


—F
—F


—Cl
—Cl


—CN
—C≡N


—OCFFF
—OCF3


—CFFF
0


—OCFF
—OCHF2


—On
—OCnH2n+1


-T-
—C≡C—


ndm-
CnH2n+1—HC═CH—(CH2)m−1


-ndm
—(CH2)n−1—HC═CH—CmH2m+1


ndmO—
CnH2n+1—HC═CH—(CH2)m−1—O—


—Ondm
—O—(CH2)n−1—HC═CH—CmH2m+1











embedded image


Example 1

A liquid crystal composition prepared and physical properties thereof are shown below:












TABLE 2









1d1-Cy-Cy-3
15.0%



od1-Cy-Cy-1d1
15.0



2-Cy-Cy-Ph-1
5.0



3-Cy-Cy-Ph-1
7.0



1-Ph—Ph1—Ph-3d0
8.0



3-Cy-Cy-Ph3—OCFFF
10.0



3-Cy-Cy-CFFO—Ph3—F
5.0



3-Cy-Ph1—Ph3—CFFO—Ph3—F
10.0



3-Pr—Ph3—O1—Ph—OCFFF
15.0



3-Pr—Ph3—O1—Ph3—F
10.0



Tni
72.2



T-n
−33.0



Vth
1.42



γ1
67.0



ε⊥
3.57



Δε
8.37



no
1.486



Δn
0.094



Viscosity
13.1










Comparative Example 1

A liquid crystal composition prepared and physical properties thereof are shown below:












TABLE 3









1d1-Cy-Cy-3
15.0%



od1-Cy-Cy-1d1
15.0



2-Cy-Cy-Ph-1
5.0



3-Cy-Cy-Ph-1
7.0



1-Ph—Ph1—Ph-3d0
8.0



3-Cy-Cy-Ph3—OCFFF
10.0



3-Cy-Cy-CFFO—Ph3—F
5.0



3-Cy-Ph1—Ph3—CFFO—Ph3—F
10.0



3-Pr—Ph3-1O—Ph—OCFFF
15.0



3-Pr—Ph—O1—Ph3—F
10.0



Tni
67.0



T-n
−33.0



Vth
1.50



γ1
94.0



ε⊥
3.55



Δε
7.87



no
1.485



Δn
0.093



Viscosity
20.5










This liquid crystal composition does not contain a compound represented by general formula (LC0) having a -Ph3-OCH2— partial structure disclosed in this application. Although Example 1 has a larger dielectric anisotropy (Δ∈) and a high nematic phase-isotropic liquid phase transition temperature (Tni), Example 1 has viscosity substantially lower than that of Comparative Example 1, and small γ1. This shows that the combination of the present invention has outstanding benefits.


Example 2

A liquid crystal composition prepared and physical properties thereof are shown below:












TABLE 4









1d1-Cy-Cy-3
10.0%



od1-Cy-Cy-1d1
10.0



3-Cy-Cy-2
5.0



3-Pr—Ph3—O1—Ph—OCFFF
5.0



3-Pr—Ph3—O1—Ph3—F
5.0



3-Pr—Ph1—Ph3—O1—Ph3—F
10.0



3-Pr-Cy-Ph3—O1—Ph—OCFFF
5.0



3-Cy-Pr—Ph3—O1—Ph3—F
5.0



3-Cy-Cy-Ph3—O1—Ph3—F
5.0



3-Cy-Ph—Ph3—O1—Ph3—F
5.0



3-Ph—Ph1—Ph3—O1—Ph3—F
10.0



3-Ph—Ph1—Np3—F
5.0



Tni
79.2



T-n
−36.0



Vth
1.38



γ1
76.0



ε⊥
3.86



Δε
9.87



no
1.485



Δn
0.090



Viscosity
14.1










Example 3

A liquid crystal composition prepared and physical properties thereof are shown below:












TABLE 5









0d1-Cy-Cy-3
10.0%



1d1-Cy-Cy-2
10.0



1d1-Cy-Cy-3
15.0



2-Cy-Cy-Ph-1
2.0



3-Cy-Cy-Ph-1
3.0



3-Pr-Cy-Ph3—O1—Ph—OCFFF
5.0



3-Cy-Pr—Ph3—O1—Ph3—F
5.0



3-Cy-Ph3—O1—Ph—OCFFF
10.0



3-Ph—Ph3—O1—Ph—OCFFF
10.0



3-Cy-Cy-Ph3—O1—Ph3—F
10.0



3-Cy-Ph—Ph3—O1—Ph3—F
10.0



3-Ph—Ph1—Ph3—O1—Ph3—F
10.0



Tni
84.6



T-n
−31.0



Vth
1.43



γ1
72.0



ε⊥
3.71



Δε
8.41



no
1.488



Δn
0.095



Viscosity
12.8










Example 4

A liquid crystal composition prepared and physical properties thereof are shown below:












TABLE 6









1d1-Cy-Cy-2
10.0%



1d1-Cy-Cy-3
15.0



od1-Cy-Cy-1d1
15.0



3-Cy-Cy-2
2.0



2-Cy-Cy-Ph-1
3.0



3-Cy-Cy-Ph-1
5.0



1-Ph—Ph1—Ph-3d0
5.0



3-Cy-Ph—Ph3—OCFFF
5.0



3-Pr—Ph3—O1—Ph—OCFFF
5.0



3-Pr—Ph1—Ph3—O1—Ph3—F
10.0



3-Cy-Ph3—O1—Ph—OCFFF
10.0



3-Ph—Ph3—O1—Ph—OCFFF
5.0



3-Cy-Cy-Ph3—O1—Ph3—F
10.0



Tni
76.0



T-n
−39.0



Vth
1.69



γ1
60.0



ε⊥
3.39



Δε
6.40



no
1.486



Δn
0.090



Viscosity
10.7










Example 5

A liquid crystal composition prepared and physical properties thereof are shown below:












TABLE 7







Compound
Example 5



















0d1-Cy-Cy-3
10.0%



1d1-Cy-Cy-2
15.0



1d1-Cy-Cy-3
15.0



od1-Cy-Cy-1d1
5.0



3-Cy-Cy-Ph3—OCFFF
5.0



3-Cy-Ph—Ph3—OCFFF
5.0



3-Cy-Cy-CFFO—Ph3—F
5.0



3-Cy-Ph1—Ph3—CFFO—Ph3—F
5.0



3-Pr—Ph1—Ph3—O1—Ph3—F
5.0



3-Pr-Cy-Ph3—O1—Ph—OCFFF
5.0



3-Cy-Pr—Ph3—O1—Ph3—F
5.0



3-Cy-Ph3—O1—Ph—OCFFF
5.0



3-Ph—Ph3—O1—Ph—OCFFF
5.0



3-Cy-Cy-Ph3—O1—Ph3—F
5.0



3-Cy-Ph—Ph3—O1—Ph3—F
5.0



Tni
78.9



T-n
−36.0



Vth
1.44



γ1
74.0



ε⊥
3.56



Δε
8.22



no
1.484



Δn
0.081



Viscosity
13.1










Example 6

A liquid crystal composition prepared and physical properties thereof are shown below:












TABLE 8









0d1-Cy-Cy-3
10.0%



1d1-Cy-Cy-2
10.0



1d1-Cy-Cy-3
10.0



od1-Cy-Cy-1d1
10.0



3-Cy-Cy-Ph-1
7.0



1-Ph—Ph1—Ph-3d0
8.0



3-Pr—Ph1—Ph3—O1—Ph3—F
10.0



3-Pr-Cy-Ph3—O1—Ph—OCFFF
10.0



3-Ph—Ph3—O1—Ph—OCFFF
10.0



3-Cy-Ph—Ph3—O1—Ph3—F
5.0



3-Ph—Ph1—Ph3—O1—Ph3—F
10.0



Tni
91.8



T-n
−36.0



Vth
1.53



γ1
79.0



ε⊥
3.54



Δε
7.52



no
1.490



Δn
0.110



Viscosity
14.3










Example 7

A vertical alignment film was formed on a first substrate that had a pair of comb-shaped transparent electrodes. Another vertical alignment film was formed on a second substrate that had no electrode structure. The first substrate and the second substrate were formed into an IPS empty cell having a gap spacing of 4.0 μm. The liquid crystal composition of Example 1 was poured into the empty cell to prepare a liquid crystal display device.


To 99% of the liquid crystal composition of Example 1, 1% of a polymerizable compound represented by formula (PC-1)-3-1 was added and homogeneously dissolved:




embedded image



As a result, a polymerizable liquid crystal composition CLC-A was obtained. The physical properties of CLC-A were substantially the same as physical properties of the liquid crystal composition of Example 1.


CLC-A was held in the IPS empty cell described above. The liquid crystal cell was then irradiated with ultraviolet light using a high-pressure mercury lamp through a filter that cuts off ultraviolet rays of 300 nm or less while applying 1.8 V square waves at a frequency of 1 KHz. The irradiation was conducted for 600 seconds while adjusting the irradiation intensity at the cell surface to be 20 mW/cm2. As a result, a vertical-alignment liquid crystal display device in which a polymerizable compound in the polymerizable liquid crystal composition was polymerized was obtained. This display device had significantly high response speed compared to the liquid crystal display device formed by using only the liquid crystal composition of Example 1.

Claims
  • 1. A liquid crystal composition having a positive dielectric anisotropy and containing one or more compounds selected from compounds represented by general formula (LC0) and one or more compounds selected from a group of compounds represented by general formula (LC1) to general formula (LC5), wherein the liquid crystal composition contains one or more compounds in which at least one of A01 and A02 in general formula (LC0) represents a tetrahydropyran-2,5-diyl group:
  • 2. The liquid crystal composition according to claim 1, wherein X01 in general formula (LC0) represents F.
  • 3. The liquid crystal composition according to claim 1, wherein the liquid crystal composition contains one or more compounds selected from the group consisting of compounds represented by general formula (LC2-1) to general formula (LC2-14) as the compound represented by general formula (LC2):
  • 4. The liquid crystal composition according to claim 1, wherein the liquid crystal composition contains one or more compounds selected from the group consisting of compounds represented by general formula (LC3-1) to general formula (LC3-32) as the compound represented by general formula (LC3):
  • 5. The liquid crystal composition according to claim 1, wherein the liquid crystal composition contains one or more compounds selected from the group consisting of compounds represented by general formula (LC4-1) to general formula (LC4-23) as the compound represented by general formula (LC4):
  • 6. The liquid crystal composition according to claim 1, wherein the liquid crystal composition contains one or more compounds selected from the group consisting of compounds represented by general formula (LC5-1) to general formula (LC5-26) as the compound represented by general formula (LC5):
  • 7. The liquid crystal composition according to claim 1, wherein the liquid crystal composition contains 5 to 50% by mass of one or more compounds in which at least one of A01 and A02 in general formula (LC0) represents a tetrahydropyran-2,5-diyl group.
  • 8. The liquid crystal composition according to claim 1, wherein the liquid crystal composition contains one or more optically active compounds.
  • 9. The liquid crystal composition according to claim 1, wherein the liquid crystal composition contains one or more compounds in which at least one of Z01, Z02, Z31 to Z42, Z51, and Z52 in general formula (LC0) and general formula (LC3) to general formula (LC5) represents —CF2O— or —OCF2—.
  • 10. The liquid crystal composition according to claim 1, wherein the liquid crystal composition contains 30 to 70% by mass of the compound represented by general formula (LC5) and has a viscosity η of 20 mPa·s or less at 20° C.
  • 11. The liquid crystal composition according to claim 1, wherein the liquid crystal composition contains one or more polymerizable compounds.
  • 12. The liquid crystal composition according to claim 1, wherein the liquid crystal composition contains one or more antioxidants.
  • 13. The liquid crystal composition according to claim 1, wherein the liquid crystal composition contains one or more UV absorbers.
  • 14. A liquid crystal display device using the liquid crystal composition according to claim 1.
  • 15. An active matrix driving liquid crystal display device using the liquid crystal composition according to claim 1.
  • 16. A TN-mode, OCB-mode, ECB-mode, IPS-mode, or VA-IPS-mode liquid crystal display device using the liquid crystal composition according to claim 1.
  • 17. A polymer-stabilized TN-mode, OCB-mode, ECB-mode, IPS-mode, or VA-IPS-mode liquid crystal display device that uses the liquid crystal composition according to claim 11 and is produced by polymerizing the polymerizable compounds in the liquid crystal composition in the absence or presence of applied voltage.
  • 18. The liquid crystal display device according to claim 14, wherein an alignment layer that has a surface that comes into contact with liquid crystal molecules and causes the liquid crystal molecules to align horizontally, tilt, or align vertically includes an alignment film containing at least one compound selected from polyimide (PI), polyamide, chalcone, cinnamate, and cinnamoyl.
  • 19. The liquid crystal display device according to claim 18, wherein the alignment layer according to claim 18 further includes a polymerizable liquid crystal compound or a polymerizable non-liquid crystal compound.
  • 20. The liquid crystal display device according to claim 18, wherein an alignment film prepared by an optical alignment technology is formed as the alignment layer at the surface that comes into contact with the liquid crystal composition.
Priority Claims (1)
Number Date Country Kind
2012-183220 Aug 2012 JP national
PCT Information
Filing Document Filing Date Country Kind
PCT/JP2013/070057 7/24/2013 WO 00
Publishing Document Publishing Date Country Kind
WO2014/030481 2/27/2014 WO A
US Referenced Citations (39)
Number Name Date Kind
5730904 Bartmann et al. Mar 1998 A
5733477 Kondo et al. Mar 1998 A
5800734 Buchecker et al. Sep 1998 A
6207076 Koga et al. Mar 2001 B1
6210603 Kondo et al. Apr 2001 B1
6254941 Kondou et al. Jul 2001 B1
7198827 Takeuchi et al. Apr 2007 B1
8916718 Tojo et al. Dec 2014 B2
9039929 Kaneoya et al. May 2015 B2
9079836 Tojo et al. Jul 2015 B2
20020166994 Kondo et al. Nov 2002 A1
20030197153 Heckmeier et al. Oct 2003 A1
20050012073 Goulding et al. Jan 2005 A1
20060061699 Kirsch et al. Mar 2006 A1
20060263542 Kirsch et al. Nov 2006 A1
20060286308 Kirsch et al. Dec 2006 A1
20070134444 Harding et al. Jun 2007 A1
20070205396 Czanta et al. Sep 2007 A1
20090103011 Bernatz et al. Apr 2009 A1
20090230355 Czanta et al. Sep 2009 A1
20090302273 Tanaka Dec 2009 A1
20100294991 Saito et al. Nov 2010 A1
20110001090 Wittek et al. Jan 2011 A1
20110037912 Saito et al. Feb 2011 A1
20110233466 Jansen et al. Sep 2011 A1
20110253934 Lietzau et al. Oct 2011 A1
20110291048 Hamano et al. Dec 2011 A1
20110315925 Hiraoka et al. Dec 2011 A1
20130300996 Takeuchi et al. Nov 2013 A1
20130306908 Jansen et al. Nov 2013 A1
20140225036 Kaneoya Aug 2014 A1
20140275577 Tojo et al. Sep 2014 A1
20150087847 Tojo et al. Mar 2015 A1
20150124205 Kaneoya et al. May 2015 A1
20150159086 Kaneoya et al. Jun 2015 A1
20150184076 Kaneoya et al. Jul 2015 A1
20150203757 Kaneoya et al. Jul 2015 A1
20150218451 Kaneoya et al. Aug 2015 A1
20150322343 Kaneoya et al. Nov 2015 A1
Foreign Referenced Citations (35)
Number Date Country
1184462 Jun 1998 CN
44 16 256 Nov 1994 DE
10 2009 009 631 Sep 2009 DE
102010015824 Mar 2011 DE
112013004132 May 2015 DE
0 882 696 Dec 1998 EP
8-283183 Oct 1996 JP
9-157202 Jun 1997 JP
10-130187 May 1998 JP
2001-019649 Jan 2001 JP
2001-026560 Jan 2001 JP
2001011458 Jan 2001 JP
2003-183656 Jul 2003 JP
2005-232214 Sep 2005 JP
2005-250223 Sep 2005 JP
2007-23071 Feb 2007 JP
2007-503487 Feb 2007 JP
2007-177241 Jul 2007 JP
2007-277127 Oct 2007 JP
2008-222588 Sep 2008 JP
2009-215556 Sep 2009 JP
2011-37998 Feb 2011 JP
2011-148761 Aug 2011 JP
2011-168530 Sep 2011 JP
2011-195587 Oct 2011 JP
5263461 Aug 2013 JP
10-2006-0119879 Nov 2006 KR
9632365 Oct 1996 WO
9823564 Jun 1998 WO
2009150963 Dec 2009 WO
2012043387 Apr 2012 WO
2012100809 Aug 2012 WO
2012161178 Nov 2012 WO
2013018796 Feb 2013 WO
2014030481 Feb 2014 WO
Non-Patent Literature Citations (34)
Entry
International Search Report dated Sep. 17, 2013, issued in corresponding application No. PCT/JP2013/070057.
Written Opinion of the International Searching Authority dated Sep. 17, 2013, issued in corresponding application No. PCT/JP2013/070057.
International Search Report of PCT/JP2012/069461, dated Sep. 18, 2012, counterpart to U.S. Appl. No. 14/236,547.
Office Action dated Jan. 21, 2014, issued in Japanese Application No. 2013-553696, w/English translation (4 pages), counterpart to U.S. Appl. No. 14/436,181.
Decision to Grant a Patent dated Apr. 1, 2014, issued in Japanese Application No. 2013-553696, w/English translation (3 pages), counterpart to U.S. Appl. No. 14/436,181.
International Search Report dated Oct. 22, 2013, issued in International Application No. PCT/JP2013/073968, counterpart of U.S. Appl. No. 14/436,213.
International Search Report dated Oct. 23, 2013, issued in International Application No. PCT/JP2013/073967 (2 pages), counterpart to U.S. Appl. No. 14/436,181.
German Office Action dated Nov. 26, 2015, issued in German Patent Application No. 11 2013 005 035.8, with English translation (10 pages), counterpart of U.S. Appl. No. 14/436,213.
German Office Action dated Nov. 27, 2015, issued in German Patent Application No. 11 2013 005 036.6, with English translation (10 pages), counterpart of U.S. Appl. No. 14/436,181.
Decision to Grant a Patent dated Apr. 1, 2014, issued in Japanese Application No. 2013/553697, w/English translation (3 pages), counterpart of U.S. Appl. No. 14/436,213.
Written Opinion of the International Searching Authority dated Sep. 17, 2013 issued in counterpart Application No. PCT/JP2013/070058.
International Search Report dated Sep. 17, 2013 issued in corresponding application No. PCT/JP2013/070058.
International Search Report dated Sep. 17, 2013, issued in application No. PCT/JP2013/070057, counterpart to U.S. Appl. No. 14/419,308 (5 pages).
Written Opinion of the International Searching Authority dated Sep. 17, 2013, issued in application No. PCT/JP2013/070057, counterpart to U.S. Appl. No. 14/419,308 (7 pages).
English Translation of DE102010015824.
English Translation of JP2001011458.
Notification of Reasons for Refusal dated Jan. 21, 2014, issued in corresponding Japanese Application No. 2013-553697, w/English translation (4 pages).
International Search Report dated Nov. 26, 2013, issued in corresponding Application No. PCT/JP2013/073127.
International Search Report dated Nov. 26, 2013, issued in corresponding Application No. PCT/JP2012/069461.
Notice of Allowance dated Mar. 15, 2016, issued in U.S. Appl. No. 14/221,015 (13 pages).
Notification of Reasons for Refusal dated Jan. 21, 2014, issued in corresponding Japanese Application No. 2013-553696, w/English translation (4 pages).
Non Final Office Action dated Jul. 30, 2015, issued in U.S. Appl. No. 14/421,015.
Final Office Action dated Dec. 3, 2016, issued in U.S. Appl. No. 14/421,015.
Non Final Office Action dated Apr. 21, 2016, issued in U.S. Appl. No. 14/421,015.
Final Office Action dated Aug. 3, 2016, issued in U.S. Appl. No. 14/421,015.
Non Final Office Action dated Jan. 14, 2016, issued in U.S. Appl. No. 14/436,181.
Final Office Action dated Jul. 26, 2016, issued in U.S. Appl. No. 14/436,181.
Non Final Office Action dated Jan. 20, 2016, issued in U.S. Appl. No. 14/436,213.
Final Office Action dated Aug. 1, 2016, issued in U.S. Appl. No. 14/436,213.
Non Final Office Action dated Aug. 20, 2015, issued in U.S. Pat. No. 9,321,961.
Notice of Allowance dated Jan. 4, 2016, issued in U.S. Pat. No. 9,321,961.
Notice of Allowance dated Mar. 3, 2015, issued in U.S. Pat. No. 9,039,929.
Non Final Office Action Sep. 5, 2014m issued in U.S. Pat. No. 9,039,929.
Final Office Action dated Nov. 19, 2014, issued in U.S. Pat. No. 9,039,929.
Related Publications (1)
Number Date Country
20150184076 A1 Jul 2015 US